Bmp4 expression is tightly regulated during embryonic tooth development, with early expression in the dental epithelial placode leading to later expression in the dental mesenchyme. Msx1 is among several transcription factors that are induced by epithelial Bmp4 and that, in turn, are necessary for the induction and maintenance of dental mesenchymal Bmp4 expression. Thus, Msx1 −/− teeth arrest at early bud stage and show loss of Bmp4 expression in the mesenchyme. Ectopic expression of Bmp4 rescues this bud stage arrest. We have identified Tbx2 expression in the dental mesenchyme at bud stage and show that this can be induced by epithelial Bmp4. We also show that endogenous Tbx2 and Msx1 can physically interact in mouse C3H10T1/2 cells. In order to ascertain a functional relationship between Msx1 and Tbx2 in tooth development, we crossed Tbx2 and Msx1 mutant mice. Our data show that the bud stage tooth arrest in Msx1 −/− mice is partially rescued in Msx1
INTRODUCTION
The formation of a bud-like structure from an epithelial placode is a common occurrence in the development of many organs, including the mammary gland, lung, kidney, hair and tooth. Tooth development begins with induction and thickening of the odontogenic ectoderm to form the dental placode at ~E12.5. This initiates an epithelial-mesenchymal signaling cascade that results in invagination of the dental epithelium to form a bud-like structure and condensation of the underlying neural crest-derived mesenchyme by E13.5 (bud stage). Subsequently, by E14.5, the bud-like structure flattens and the epithelial cells at its center condense to form the primary enamel knot (EK), which serves as a signaling center to initiate tooth morphogenesis and patterning. Meanwhile, the epithelium of the bud continues to proliferate outward and folds to surround the dental papilla mesenchyme (cap stage) (Thesleff and Mikkola, 2002; Bei, 2009) .
The bud-to-cap stage transition appears to be a critical checkpoint in dental development. Mouse mutants for several transcription factors necessary for tooth development, including Msx1, Pax9, Lef1 and Runx2, manifest bud stage arrest (Satokata and Maas, 1994; van Genderen et al., 1994; Peters et al., 1998; D'Souza et al., 1999) . Analysis of these mouse mutants has revealed that these transcription factors induce and maintain Bmp4 signaling, which is required for the bud-to-cap stage transition.
Bud stage arrest has been extensively studied in Msx1 −/− mice, in which mesenchymal Bmp4 expression is lost entirely (Chen et al., 1996) . We know that the addition of exogenous Bmp4 can rescue the Msx1 −/− bud stage arrest (Bei et al., 2000; Zhao et al., 2000) . However, it is still unclear how Msx1 activates or maintains Bmp4 expression. Several transcription factors, including Pax9 (Ogawa et al., 2006) , Osr2 (Zhou et al., 2011) and Barx1 (Miletich et al., 2011) , have been shown to regulate Bmp4 expression coordinately with Msx1. Since Msx1 functions primarily as a repressor (Catron et al., 1995; Zhang et al., 1996) , it is generally believed that Msx1 activates Bmp4 indirectly. However, recent studies indicate that certain Msx1 protein-protein interactions can result in synergistic activation of target promoters directly (Ogawa et al., 2006; Zhao et al., 2013) . Furthermore, O'Connell et al. (O'Connell et al., 2012) have shown that epithelial Bmp4 can diffuse to the mesenchyme and signal back to the epithelium. Consistent with this, Bmpr1a receptor knockout in the dental epithelium results in bud stage arrest (Andl et al., 2004; Liu et al., 2005; O'Connell et al., 2012) . Recently, Jia et al. (Jia et al., 2013) have shown that mesenchymal Bmp4 is not required for upper molar development. However, the EK and epithelial Bmp4 are still present in these upper molars, indicating that epithelial Bmp4 diffusion and signaling are still maintained in the mesenchyme. By contrast, the lower molars lacking mesenchymal Bmp4 expression do not form an EK or show epithelial Bmp4 expression, and fail to progress beyond the bud stage. Thus, Bmp4 signaling is governed by a complex regulatory mechanism that is distinct in upper and lower molars during the bud-to-cap stage transition.
The T-box family of transcription factors has been shown to play crucial roles in the morphogenesis of many tissues, primarily the heart, bone and mammary gland (Papaioannou and Silver, 1998; Showell et al., 2004; Naiche et al., 2005) . Mutations in several TBX genes have been identified in human syndromes affecting these tissues, including TBX1 mutations in DiGeorge syndrome, TBX3 mutations in ulnar-mammary syndrome (UMS) and TBX5 mutations in Holt-Oram syndrome (Packham and Brook, 2003; Naiche et al., 2005) . Although some UMS patients with TBX3 mutations manifest dental abnormalities (Bamshad et al., 1999) , a role for TBX genes in dental development has remained uncharacterized. Recently, a role for Tbx1 has been described in the maintenance of the epithelial stem cell compartment of the mouse incisor (Catón et al., 2009) .
Here, we report Tbx2 as the first T-box transcription factor to be identified in the dental mesenchyme at bud stage. We further show that Tbx2 can physically and genetically interact with Msx1. Importantly, we show that reduction in Tbx2 gene dosage partially rescues Msx1 −/− tooth arrest by restoring the EK and mesenchymal Bmp4 expression.
MATERIALS AND METHODS

Embryos and genotyping
Msx1
+/− and Tbx2 +/− mice were maintained on a BALB/c (Satokata and Maas, 1994 ) and a mixed C57BL/6×129/SvEv × ICR background (Harrelson et al., 2004) , respectively. Msx1 −/− ;Tbx2 −/− (n=0, lethal), Msx1-Tbx2 compound mutants (n=24); embryos were collected from intercrossing Msx1 +/− ;Tbx2 +/− mice at E14.5 and E15.5. The day of plug discovery was designated E0.5. Genotyping of Msx1 and Tbx2 genes was performed as previously described (Satokata and Maas, 1994; Harrelson et al., 2004) .
Histology, in situ hybridization and immunohistochemistry
For histological analysis, tissues were fixed in 4% paraformaldehyde, dehydrated in ethanol, and embedded in paraffin. Serial sections at 7 µm were stained with Hematoxylin/Eosin. Murine Tbx2 and Bmp4 cDNA fragments were used to generate antisense probes. The RNA probes were digoxigenin (DIG) labeled with DIG-UTP (Roche) using T7 RNA polymerase. In situ hybridization was performed as previously described (Bei and Maas, 1998) . Immunohistochemistry was performed on 6 μm paraffin sections using a rabbit anti-Tbx2 antibody (Sigma, HPA008586) at 1/100 dilution according to the manufacturer's protocol.
Bead implantation assay
Affi-Gel blue agarose beads (100-200 mesh, 75-150 mm diameter; BioRad) and/or heparin acrylic beads (white in color; Sigma) were incubated with 100 ng/ml recombinant human BMP4 (Genetics Institute, Cambridge, MA, USA) at 37°C for 30 minutes. Control beads were soaked with 100 ng/ml BSA under the same conditions. Wild-type and Msx1 -/-tooth rudiments were collected from E13.5 embryos. The dental epithelium was then removed from the rudiments following dispase treatment. Proteinsoaked beads were washed in PBS and placed on top of the mesenchyme. All explants were cultured on filters, supported by metal grids in Dulbecco's minimal essential medium (D-MEM) supplemented with 10% fetal bovine serum (FBS) and 10% chick embryo extract at 37°C for 48 hours. After culture, the explants were processed for standard in situ hybridization using the Tbx2 probe.
GST-pulldown assay
GST-Msx1 protein was prepared from bacterial culture carrying pGEX4T-Msx1 plasmid.
35 S-labeled Tbx2 protein was prepared using an in vitro transcription and translation kit (Promega). GST-Msx1 or GST protein alone was immobilized on glutathione Sepharose beads (Amersham Pharmacia Biotech) and incubated with 35 S-labeled Tbx2 protein. Following incubation, the beads were centrifuged and washed three times with buffer comprising 50 mM Tris (pH 7.0) and 140 mM NaCl. The beads were resuspended in 5× SDS sample buffer to a final 1× concentration, boiled for 5 minutes, and loaded on a 12.5% SDS-polyacrylamide gel for electrophoresis. Proteins were transferred to Immobilon-P polyvinylidene difluoride filters (Millipore) and exposed to autoradiography film to detect the bound 35 S-labeled Tbx2 protein.
Cell culture and co-immunoprecipitation assays
C3H10T1/2 cells (ATCC) were cultured in high-glucose Dulbecco's modified Eagle medium supplemented with 10% (v/v) FBS, 10 units/ml penicillin and 10 µg/ml (Invitrogen) under 5% CO 2 . Approximately 1.5×10 6 C3H10T1/2 cells were cultured in 100 mm dishes for 24 hours. Cells were lysed in 500 μl modified RIPA buffer (1% SDS, 20 mM Tris-HCl pH 8.0, 1% NP40, 131 mM NaCl, 10% glycerol, 2 mM EDTA) containing Protease Inhibitor Cocktail (Roche). The lysate was then pre-cleared for 30 minutes with protein A-agarose beads (Pierce) prior to incubation with anti-Msx1 antibody (Sigma, M0944) overnight. Then, protein A-agarose beads were added to the lysate, incubated for 2 hours, washed three times with lysis buffer and resuspended in SDS sample buffer. Samples were loaded onto an 11% SDS-polyacrylamide gel for electrophoresis. Western blots were performed with the anti-Tbx2 antibody (Sigma) to detect immunoprecipitated Tbx2 protein using ECL reagents (Pierce) according to the manufacturer's protocol.
Lentiviral knockdown and qPCR analysis
Lentiviral particles expressing shRNA against Tbx2 were purchased from Sigma (TRCN0000084471). C3H10T1/2 cells were grown in 24-well plates and transduced at a multiplicity of infection of 5 for 24 hours. RNA was collected from cells after three passages following transduction. Quantitative (q) PCR analysis was performed using a Roche LightCycler 480 following the manufacturer's instructions. Primers used were (5Ј-3Ј, forward and reverse): Tbx2, CAACACTGTGGGGGTGGCCTC and CCTGGGATGCTTTCCGAAGGAACAC; Msx1, ACCCATGATCCA -GGGCTGTCTCG and CCGAGTGGCAAAGAAGTCATAGCAGC; Bmp4, TTGAGTACCCGGAGCGTCCCG and CAGAGCTCTCAC -TGGTCCCTGGG.
RESULTS AND DISCUSSION
Tbx2 is expressed in the dental mesenchyme and can be induced by Bmp4 Tbx2 expression was detected in the dental mesenchyme in both upper and lower molars from E12.5 to E16.5 using immunohistochemistry (Fig. 1A-D) . At E13.5 bud stage, the expression domain largely overlaps with that known for Msx1 (Fig. 1B ). There appears to be reduced Tbx2 expression on the lingual aspect of the developing upper and lower molars (Fig. 1,  arrows) . In Msx1 −/− samples, Tbx2 expression is maintained (Fig. 1E,F) , showing that Msx1 is not required for Tbx2 expression in bud stage dental mesenchyme. The expression domain of Tbx2 appears dispersed in the Msx1 −/− arrested tooth bud towards the lingual side (Fig. 1F) , which might indicate an Msx1-dependent suppression of Tbx2 expression ligually, or it could be a consequence of loss of condensed dental mesenchyme surrounding the mutant bud. Tbx2 is the first T-box factor to be identified in the developing dental mesenchyme at bud stage, with an expression pattern similar to that of Msx1. Previously, only Tbx1 had been shown to function in the mouse lower incisor epithelium, where it maintains the incisor stem cell niche, called the cervical loop (Catón et al., 2009 ). The persistence of Tbx2 expression in the Msx1 −/− arrested tooth buds shows that Tbx2 expression is not dependent on that of Msx1.
Epithelial Bmp4 induces mesenchymal Msx1 expression, which then leads to the induction and maintenance of mesenchymal Bmp4 expression, sometimes referred to as the Bmp4-Msx1-Bmp4 pathway (Bei, 2009) . We determined whether epithelial Bmp4 could induce mesenchymal Tbx2 expression, similarly to that of Msx1. Indeed, bead implantation experiments using Bmp4-soaked beads resulted in activation of Tbx2 expression in the dental mesenchyme (Fig. 1G) . This activation was also present in Msx1 −/− tissue (Fig. 1H) , showing that Msx1 is not required to mediate the Bmp4 effect. Analysis of several other T-box factors also indicates activation downstream of initial Bmp signaling (Yamada et al., 2000; Naiche et al., 2005; Behesti et al., 2006; Abrahams et al., 2010) . Thus, our data are consistent with the model in which Bmp4 from the dental epithelial placode activates Tbx2, similarly to Msx1, in the surrounding dental mesenchyme.
Tbx2 physically interacts with Msx1
To determine whether co-expression of Msx1 and Tbx2 also results in a physical interaction between the two proteins, we performed GST-pulldown and co-immunoprecipitation assays (Fig. 2) . GSTpulldown was carried out using GST-tagged Msx1 protein in the presence of 35 S-labeled Tbx2 ( Fig. 2A) . In the presence of GSTMsx1,
35
S-Tbx2 is retained, demonstrating a physical interaction in vitro. As a control, incubation with GST protein or beads alone did not retain any 35 S-Tbx2. The co-immunoprecipitation analysis utilized C3H10T1/2 cells, a mammalian mesenchymal cell line that is appropriate for Msx1 protein-protein interaction studies (Miletich et al., 2011; Zhao et al., 2013) . C3H10T1/2 cells behave as early odontogenic precursor cells and endogenously express most of the early odontogenic proteins including Msx1 and Tbx2 (Fig. 2B) . Immunoprecipitation was performed using anti-Msx1 antibody against endogenous Msx1 (Fig. 2C) . Western blot analysis was carried out with anti-Tbx2 antibody. A Tbx2 band is visible in the input and in anti-Msx1 immunoprecipitated samples, demonstrating interaction between the endogenous proteins. As a control, beads alone did not show any retention of Tbx2 signal. These data confirm a physical interaction between Msx1 and Tbx2 proteins in vitro and in C3H10T1/2 odontogenic precursor cells. Combined with the coexpression of these two transcription factors in the dental mesenchyme, these data are consistent with a co-regulatory role for the two proteins during the bud-to-cap stage transition.
Tbx2 gene dosage reduction partially rescues
Msx1
−/− bud stage arrest Since Tbx2 is expressed in the dental mesenchyme at bud stage and physically interacts with Msx1, we examined whether they also interact genetically. We crossed Tbx2 and Msx1 mouse mutants, and did not note any defects or reduction in Mendelian ratios in Tbx2 +/− ;Msx1 +/− double heterozygotes (data not shown). We intercrossed these double heterozygotes to generate compound mutants and analyzed them at E14.5 and E15.5. We did not observe any Tbx2 −/− mice in our crosses, which is consistent with previous analyses in which Tbx2 −/− embryos showed lethality by E12.5 (Harrelson et al., 2004; Zirzow et al., 2009 ). Tbx2 null mice on a severe background (Harrelson et al., 2004) are known to die during mid-gestation, between ~E10.5 and E12.5, prior to bud stage, and
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Tbx2/Msx1 antagonism in tooth so their role at bud stage cannot be directly established in these mutants. Recently, Zirzow et al. (Zirzow et al., 2009 ) have described a genetic interaction between Tbx2 and Tbx3 mutant mice, which results in a cleft palate phenotype with variable penetrance depending on the background used. They were able to analyze E14.5 Tbx2 −/− embryos for palate defects; however, they did not report any dental anomalies (Zirzow et al., 2009 ).
In our analysis, on a mixed severe background, we were not able to collect any Tbx2 −/− embryos at E14.5 or E15. Fig. 3A with 3B,C) or incisors (Fig. 3D) . As a control we confirmed that even on our mixed background at E13.5, compared with wild type (Fig. 3E,I ), the Msx1 −/− mice showed the expected bud stage arrest phenotype (Fig. 3F,J) . However, the formal possibility remains that reduction in Msx1 gene dosage partially ameliorates a potentially severe Tbx2 null phenotype (see below).
Next, we assessed any effect of Tbx2 gene dosage reduction on the Msx1 −/− phenotype. Indeed, in E15.5 Msx1
−/−
;Tbx2 +/− embryos we noted a partial rescue of the bud stage tooth arrest (Fig. 3G,H,K,L) . The upper molars in these mice showed development well beyond bud stage, frequently with progression to form a cap-like structure resembling that of the wild type (compare Fig. 3E with 3G) . The cap-like structure (Fig. 3G) was seen in five out of six Msx1
+/− upper molars examined (83%), whereas the remaining one upper molar showed enlargement (Fig. 3H) . In anterior and posterior sections, the rescued molar still appeared arrested at bud stage (supplementary material Fig. S1A,E) , with the rescue to the cap-like structure lying mostly in the middle third of the molar (supplementary material Fig. S1B-D) . Importantly, the rescued upper molar showed an EK ( Fig. 3G ; supplementary material Fig. S2) . Surprisingly, the lower molars only showed enlargement without subsequent progression to cap stage, and appeared as elongated buds (Fig. 3K,L) . This enlargement of buds in the Msx1
;Tbx2
+/− lower molars (Fig. 3K,L) was seen in four out of six samples examined (66%); the remaining two lower molars appeared to have a bud stage arrest similar to that of Msx1 −/− lower molars (Fig. 3J) .
These data not only confirm a genetic interaction between Msx1 and Tbx2, but also suggest that they play antagonistic roles at bud stage. In addition, the Msx1 −/− upper molars appear more sensitive than lower molars to Tbx2 gene dosage reduction. This differential response is likely to be due to the presence of distinct genetic and signaling programs for upper and lower molars. For example, Runx2 has been reported to affect the lower molars more than the upper molars (Wang et al., 2005) . Similarly, Jia et al. (Jia et al., 2013) show that loss of mesenchymal Bmp4 expression leads to bud stage arrest of lower molars, but not upper molars. There is also a possibility that other Tbx factors play a role in lower molars. In contrast to the molars, the Msx1 −/− cleft palate phenotype (compare Fig. 3M with 3N ) remained unaffected in Msx1
+/− embryos (Fig. 3O) , underscoring the specificity of the genetic interaction.
Mesenchymal Bmp4 expression is restored in
Msx1
−/− ;Tbx2 +/− rescued molars Mesenchymal Bmp4 expression is an important marker for the budto-cap stage transition (Chen et al., 1996; Bei et al., 2000) . Studies show that bud stage arrest in Msx1 −/− and Pax9 −/− mice is accompanied by loss of mesenchymal Bmp4 expression (Peters and Balling, 1999; Bei et al., 2000) . We determined whether the partial rescue in Msx1
+/− compound mutants showed restoration of mesenchymal Bmp4 expression (Fig. 4A) . Indeed, similar to in
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Development 140 (13) situ analysis in wild type at E15.5 (Fig. 4A, left) , mesenchymal Bmp4 expression was present in the partially rescued upper molar (Fig. 4A, right) . Interestingly, the lower molar did not show any significant mesenchymal Bmp4 expression (supplementary material Fig. S3 ), further supporting distinct genetic regulation of Bmp4 expression in upper versus lower molars. Restoration of Bmp4 expression in the upper molar is consistent with the rescue phenotype and implies that Msx1 and Tbx2 antagonistically regulate Bmp4 expression during the bud-to-cap stage transition.
Restoration of the EK and of Bmp4 expression in Msx1
+/− dental mesenchyme suggests that Tbx2 negatively regulates Msx1-mediated odontogenic activity and Bmp4 expression, at least in upper molar development. To examine the latter, we knocked down Tbx2 in C3H10T1/2 mesenchymal cells using lentiviral particles expressing an shRNA against Tbx2 (Fig. 4B) . Knockdown of Tbx2 (**P<0.00001) resulted in a moderate but significant upregulation of Bmp4 expression (*P<0.01). As a control, Msx1 expression remained unchanged (Fig. 4B) . These results are consistent with a repressive role for Tbx2 in Bmp4 regulation.
Our genetic analysis implies that following induction by Bmp4, unlike Msx1, Tbx2 suppresses odontogenic activity and Bmp4 expression in the mesenchyme (Fig. 4C) . This is consistent with the increased Bmp4 and cyclin D1 expression seen in Tbx2-deficient palatal shelves as reported previously (Zirzow et al., 2009 ). Rescue of the bud stage arrest and restoration of mesenchymal Bmp4 simply by reduction in Tbx2 gene dosage suggests that, in the presence of Msx1, Tbx2 repression of Bmp4 is abated either by protein-protein interaction or via recruitment of a different set of co-factors. The partial nature of the rescue indicates a further requirement of Msx1 function later in tooth development.
Together, our data suggest a model (Fig. 4C ) in which initial Bmp signaling from the epithelium activates factors in the mesenchyme that not only subsequently activate and maintain Bmp signaling in odontogenesis, but also repress it, thus achieving a dynamic equilibrium that is fine-tuned for proper morphogenesis and patterning. Given the examples of interplay between Bmp signaling and Msx/Tbx factors, it is intriguing to propose that their antagonistic relationship is a general paradigm during morphogenesis in other tissues in which Msx/Tbx factors are coexpressed. These include other craniofacial regions, such as the palate where Msx1, Tbx2 and Tbx3 are co-expressed, and the mouse incisor epithelium where Msx2 and Tbx1 are co-expressed. Another example could be cardiac outflow tract morphogenesis, in which Msx1/2 and Tbx2/3 are known to be co-expressed. The latter is partly supported by the report that Msx1/2 and Tbx2/3 functionally interact in vitro in the regulation of connexin 43 in a cardiac cell line; however, in this case these factors acted coordinately to suppress connexin 43 (Boogerd et al., 2008) . Interestingly, these authors also show that repression of connexin 43 by Msx1 and Msx2 requires Tbx3 expression, suggesting the formation of a functional complex. Our data are consistent with a physical interaction between Msx and T-box factors and uncover another level of complexity in the regulation of Bmp4 signaling. Further in vivo analyses in the mouse would be valuable in clarifying the relationship between different Msx and T-box factors in cardiac, craniofacial and dental morphogenesis. and Bmp4 transcripts was performed on RNA isolated from four separate pellets each from two independent transduction experiments. Tbx2 expression is downregulated as expected (**P<0.00001). Msx1 expression is unaffected as in the control, whereas Bmp4 expression is significantly upregulated (*P<0.01). (C) Model depicting how epithelial Bmp4 from the dental placode is sufficient to induce mesenchymal expression of both Msx1 and Tbx2. Subsequently, these two transcription factors antagonistically regulate enamel knot formation and mesenchymal Bmp4 expression, hence maintaining a fine-tuned level of Bmp4. e, epithelium; m, mesenchyme; EK, enamel knot. Scale bars: 0.1 mm.
